Senegal-Made Sickle Cell Treatment Raises Hopes, Reduces Costs

Senegalese company produces first Africa-made treatment for sickle cell disease

Africa accounts for nearly 80 per cent of cases of the inherited red blood cell disorder but has relied on expensive imported medication.

Senegal-made sickle cell treatment raises hopes, reduces costs

Mamadou Tahirou is 18 but looks more like a 12-year-old. His frame is frail from the ravages of sickle cell disease, which one Senegalese laboratory hopes to attenuate with affordable drug production.

Senegal Launches First African-Made Sickle Cell Treatment

A Senegalese pharmaceutical firm has begun production of the first African-made treatment for sickle cell disease, aiming to lower costs and increase accessibility across the continent. The post Senegal Launches First African-Made Sickle Cell Treatment appeared first on Business Elites Africa.